Brief: X4 Pharmaceuticals Enters Purchase Agreement With Lincoln Park - SEC Filing
23/06/2025 22:03
June 23 (Reuters) - X4 Pharmaceuticals Inc XFOR.O: X4 PHARMACEUTICALS INC - ENTERS PURCHASE AGREEMENT WITH LINCOLN PARK - SEC FILING X4 PHARMACEUTICALS INC - CAN SELL UP TO $40 MILLION IN STOCK - SEC FILING Source text: [ID:n0001628280-25-032627] Further company coverage: XFOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule